Complement US

Complement-based Drug Development Summit (November 13-15, 2019) Get the brochure here: #complementtherapeutics

[Complement US @Complement_US]

The 3rd Annual Complement-based Drug Development Summit has officially launched! Bringing together leaders from @ApellisPharma @Ra_Pharma @AchillionPharma and more, it's sure to be a great event. Get the brochure here: https://t.co/sQa1L4GInV

[Complement US @Complement_US]

You can hear from @AchillionPharma with us in Boston next month!
https://t.co/GE7sTyTWKu

[Complement US @Complement_US]

You can hear from @Ra_Pharma CSO with us in Boston next month! Today is your last day to save on registration: https://t.co/9j1U4VDnVX

[Complement US @Complement_US]

This week is your last chance to save on admission to the Complement Summit! Don't miss the opportunity to join over 100 of your peers from the likes of
@AlexionPharma @Ra_Pharma @AchillionPharma @ApellisPharma @chemocentryxinc https://t.co/9j1U4VDnVX

[Complement US @Complement_US]

Biopharma companies, academia, patient groups, and the NIH are embracing translational medicine to increase number of drugs that can be successfully brought to market. @PharmaVOICE #biopharma #TranslationalMedicine https://t.co/Ny9zL8VdWn

[Complement US @Complement_US]

This week is your last chance to save up to $900 on your registration to hear from @Ra_Pharma @AchillionPharma @ApellisPharma @SilenceTheraPlc and more! https://t.co/9j1U4VDnVX

[Complement US @Complement_US]

https://t.co/ABQitXfhrh

[Complement US @Complement_US]

https://t.co/Kpbt3zu7Y0

[Complement US @Complement_US]

https://t.co/XL07A5v06g

[Anne Troldborg @TroldborgAnne]

Great study by Dennis Vestergaard et al. #Immunology #structure @ComplementSoc @Complement_US @ComplementUK @AarhusUni

[Nature Reviews Nephrology @NatRevNeph]

Dysregulation of the #complement cascade in #C3glomerulopathy. https://t.co/L0EqXvP2Oh

[Complement US @Complement_US]

Today's your last day to save up to $1100 on admission to the only industry-focused Complement Therapeutic meeting, don't miss out!
https://t.co/9j1U4VUYNv

[Complement US @Complement_US]

Ahead of the 3rd Annual Complement-based Drug Development Summit we spent time putting together a landscape of complement therapeutic clinical trials. Download information on trials from @AlexionPharma @Ra_Pharma @ionispharma @chemocentryxinc and more! https://t.co/qyfDiMSVh5

[Complement US @Complement_US]

This week is your last chance to save up to $1100 on your registration to the 3rd Annual Complement-based Drug Development Summit. Join us to future-proof your complement therapeutic development: https://t.co/9j1U4VDnVX

[aHUS Alliance Action @aHUSAllianceAct]

#DrugDiscovery is always of interest for the atypical HUS #raredisease community. 3rd @Complement_US #Drug Development Summit in Boston Nov 13-15. @SilenceTheraPlc on #siRNA approach for treatment of #Complement-mediated diseases. Perhaps #aHUS? https://t.co/qtqVuVqeJm #pharma

[Complement US @Complement_US]

Our excellent speaker faculty can't wait to tell you about their complement therapeutic development this November. We have speakers from @AchillionPharma @ApellisPharma @Novartis @Roche @genentech @Ra_Pharma and more. See who else here: https://t.co/M72D2xwFTt

[Complement US @Complement_US]

https://t.co/zGAuKIP4cR

[Complement US @Complement_US]

Great news for @AchillionPharma with their Factor D inhibitor displaying amazing results in a Phase I study! Hear from their CMO Steven Zelenkofske at the Complement-based Drug Development Summit in November!
https://t.co/txElSzudv8

[Complement US @Complement_US]

Delighted to have @MachaonDx supporting us again at the 3rd Annual Complement-based Drug Development Summit. Find out more about them on our partner page: https://t.co/ZYd6d6ltxO

[Complement US @Complement_US]

Hear from @SilenceTheraPlc with us in Boston this November!
https://t.co/ioPJWiI3Se